Capricor Therapeutics (CAPR) Non-Current Assets (2010 - 2026)

Capricor Therapeutics' Non-Current Assets history runs 17 years deep, the most recent figure standing at $43.2 million for Q1 2026.

• In Q1 2026, Non-Current Assets rose 474.78% year-over-year to $43.2 million; the TTM figure through Mar 2026 stood at $111.1 million (up 278.68% YoY), while the FY2025 annual figure was $33.0 million, up 365.2% from the prior year.
• Non-Current Assets was $43.2 million for Q1 2026 at Capricor Therapeutics, up from $33.0 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $43.2 million in Q1 2026 to a low of $5.3 million in Q1 2022.
• Historically, Non-Current Assets has averaged $11.9 million across 5 years, with a median of $7.5 million in 2025.
• The sharpest annual moves came in 2024 and 2026: Non-Current Assets dropped 9.94% in 2024, then surged 474.78% in 2026.
• A 5-year view of Non-Current Assets shows it stood at $7.2 million in 2022, then advanced by 9.33% to $7.9 million in 2023, then retreated by 9.94% to $7.1 million in 2024, then surged by 365.2% to $33.0 million in 2025, then jumped by 30.86% to $43.2 million in 2026.
• The last three Non-Current Assets figures came in at $43.2 million (Q1 2026), $33.0 million (Q4 2025), and $25.5 million (Q3 2025), per Business Quant data.